ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,164.90
-0.22%
Dow Jones
40,954.48
1.85%
Gold vs US Dollar
2,470.39
0.07%
Brent Oil
83.075
-0.29%
Bitcoin
65,835.00
1.14%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
Unknown symbol
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
17/07/202406:35UK RegulatoryFitch Ratings re-confirmed BB+ credit rating with a stable outlook for Akropolis GroupTG:A3KR0SAkropolis Group
17/07/202406:31PR Newswire (US)111, Inc. to Participate in Fireside Chat with Water Tower Research on July 18, 2024NASDAQ:YI111 Inc
17/07/202406:30Alliance NewsAlliance NewsAlliance News UK - start of day
17/07/202406:30UK RegulatoryBW Energy: Signs Letter Agreement to acquire shares in Reconnaissance Energy Africa and 20% interest in onshore exploration license PEL 73 in Namibia  TG:6BWBW Energy Limited
17/07/202406:30UK RegulatoryBGHL (GBP): NAV(s)EU:BGHSBoussard and Gavaudan Holding
17/07/202406:30UK RegulatoryBGHL (EUR): NAV(s)EU:BGHLBoussard And Gavaudan Holding Limited
17/07/202406:30UK RegulatoryMcPhy Energy: McPhy completes the disposal of its refueling stations business to AtaweyTG:M6PMcphy Energy
17/07/202406:30UK RegulatoryInside information: Phase III ARANOTE trial of darolutamide in combination with androgen deprivation therapy in men with metastatic hormone-sensitive prostate cancer meets primary endpointBIT:1ORNBVOrion Corporation
17/07/202406:30UK RegulatorySampo plc’s share buybacks 16 July 2024
17/07/202406:30UK RegulatoryMcPhy Energy : McPhy finalise l’opération de cession de son activité stations de recharge hydrogène à AtaweyEU:MCPHYMcphy Energy
17/07/202406:30UK RegulatoryMcPhy Energy : McPhy finalise l’opération de cession de son activité stations de recharge hydrogène à AtaweyLSE:0QTFMcphy Energy Sas
17/07/202406:30UK RegulatoryMcPhy Energy: McPhy completes the disposal of its refueling stations business to AtaweyLSE:0QTFMcphy Energy Sas
17/07/202406:30UK RegulatoryInside information: Phase III ARANOTE trial of darolutamide in combination with androgen deprivation therapy in men with metastatic hormone-sensitive prostate cancer meets primary endpointTG:OFKOrion Corporation
17/07/202406:30UK RegulatoryBGHL (GBP): NAV(s)LSE:BGHSBoussard & Gavaudan Holding Limited
17/07/202406:30UK RegulatoryTGS Secures Ocean Bottom Node Data Acquisition Contract in North AmericaTG:TGCTGS ASA
17/07/202406:30UK RegulatoryONWARD® Medical Publishes Annual Sustainability SummaryEU:ONWDOnward Medical NV
17/07/202406:30UK RegulatoryBGHL (EUR): NAV(s)LSE:BGHLBoussard & Gavaudan Holding Limited
17/07/202406:30UK RegulatoryMcPhy Energy : McPhy finalise l’opération de cession de son activité stations de recharge hydrogène à AtaweyTG:M6PMcphy Energy
17/07/202406:30UK RegulatoryMcPhy Energy: McPhy completes the disposal of its refueling stations business to AtaweyEU:MCPHYMcphy Energy
17/07/202406:09PR Newswire (US)CGTN: Why is deepening reform so important for China?
17/07/202406:00UK RegulatoryTGS Imaging AnyWare Software licensed to Shell in Four-year DealTG:TGCTGS ASA
17/07/202406:00UK RegulatoryKadri Haldre to become new Management Board member of LHV Group and LHV Pank
17/07/202406:00UK RegulatoryStart of Day Message
17/07/202406:00UK RegulatoryASML reports €6.2 billion total net sales and €1.6 billion net income in Q2 2024EU:ASMLASML Holding NV
17/07/202406:00UK RegulatoryASML reports €6.2 billion total net sales and €1.6 billion net income in Q2 2024BIT:ASMLASML Holding NV
17/07/202406:00UK RegulatoryASML reports €6.2 billion total net sales and €1.6 billion net income in Q2 2024XE:ASMEASML Holding NV
17/07/202406:00UK RegulatoryASML reports €6.2 billion total net sales and €1.6 billion net income in Q2 2024BIT:1ASMLASML Holding NV
17/07/202406:00UK RegulatoryBorregaard ASA: EBITDA1 of NOK 510 million in the 2nd quarterTG:BO4Borregaard ASA
17/07/202406:00UK RegulatoryASML reports €6.2 billion total net sales and €1.6 billion net income in Q2 2024TG:ASMEASML Holding NV
17/07/202406:00UK RegulatoryAtlas responds to recommendation of the Independent Committee of the Board of Directors of Millicom International Cellular S.A.

Your Recent History

LSE
GGP
Greatland Gold
LSE
AAU
Ariana Resources
LSE
SYME
Supply@me Capital
LSE
POS
Plexus
LSE
MIN
Minoan
LSE
BRBY
Burberry
LSE
MNL
Manchester & London Inve...
LSE
ENET
Ethernity Networks
LSE
SOLG
Solgold
LSE
ITM
Itm Power
LSE
CPX
Cap-xx
LSE
AXL
Arrow Exploration
LSE
PRTC
Puretech Health
LSE
PET
Petrel Resources
LSE
GKP
Gulf Keystone Petroleum
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved